Next-generation sequencing and clinical histocompatibility testing.

Cornaby, Caleb; Schmitz, John L; Weimer, Eric T

Cornaby, Caleb; Schmitz, John L; Weimer, Eric T.

Affiliation

Cornaby C; McLendon Clinical Laboratories, UNC Health, Chapel Hill, NC, USA.
Schmitz JL; McLendon Clinical Laboratories, UNC Health, Chapel Hill, NC, USA; Department of Pathology & Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Weimer ET; McLendon Clinical Laboratories, UNC Health, Chapel Hill, NC, USA; Department of Pathology & Laboratory Medicine, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA. Electronic address: eric_weimer@med.unc.edu.

Hum Immunol ; 82(11): 829-837, 2021 Nov.

Article in En | MEDLINE | ID: mdl-34521569

Subject(s)

Donor Selection/methods; HLA Antigens/genetics; High-Throughput Nucleotide Sequencing; Histocompatibility Testing/methods; Alleles; Graft Rejection/immunology; Graft Rejection/prevention & control; Graft vs Host Disease/immunology; Graft vs Host Disease/prevention & control; HLA Antigens/immunology; Hematopoietic Stem Cell Transplantation/adverse effects; Humans; Laboratories, Clinical; Organ Transplantation/adverse effects; Sequence Analysis, DNA

Key words

HLA; Histocompatibility; NGS; Next-generation sequencing; Transplant

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Histocompatibility Testing / Donor Selection / High-Throughput Nucleotide Sequencing / HLA Antigens Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Hum Immunol Year: 2021 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google